Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F Journal Article


Authors: Hiyama, H.; Iavarone, A.; Reeves, S. A.
Article Title: Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F
Abstract: The control of cell cycle progression is orchestrated by an extraordinary diverse and dynamic in function group of proteins. Critical in the progression are the actions of the E2F family of transcription factors which regulate the expression of genes necessary for the G1/S transition and the WAF/CIP/KIP family of cdk inhibitors which can inhibit cell cycle progression. In this report, we have identified E2F binding sites in both the human and mouse p21 promoters that bind E2F protein complexes from nuclear extracts in a cell cycle-dependent manner. In ectopic expression experiments we determined that E2F1, but not E2F4, can strongly transactivate the human p21 gene through these E2F binding sites which are located in the -215/+1 region of the p21 gene. The transactivation of the p21 gene through regulatory elements within the -215/+1 region of the promoter was correlated with increased levels of endogenous E2F1 and p21 proteins at the G1/S boundary. The significance of transactivation of the p21 gene by E2F is that p21 function is important in cell cycle progression as well as for cell cycle arrest. Indeed, E2F- induced levels of p21 protein during the G1/ S transition is consistent with the recent findings demonstrating that p21 acts as an assembly factor for kinase active cyclin/cdk/p21 complexes.
Keywords: controlled study; human cell; promoter region; dna-binding proteins; nonhuman; glioma; animal cell; mouse; animals; cell cycle proteins; mice; cell cycle; cell cycle s phase; protein binding; tumor cells, cultured; animalia; transcription factors; gene expression regulation; gene expression regulation, neoplastic; enzyme inhibitors; transcription factor e2f; carrier proteins; transactivation; transcription; binding site; binding sites; cyclin-dependent kinase inhibitor p21; cycline; cyclins; protein p21; phosphotransferase; cell cycle g1 phase; g1 phase; s phase; p21; transcription factor dp1; e2f1 transcription factor; promoter regions (genetics); e2f; e2f transcription factors; humans; human; priority journal; article; e2f4 transcription factor
Journal Title: Oncogene
Volume: 16
Issue: 12
ISSN: 0950-9232
Publisher: Nature Publishing Group  
Date Published: 1998-03-26
Start Page: 1513
End Page: 1523
Language: English
PUBMED: 9569018
PROVIDER: scopus
DOI: 10.1038/sj.onc.1201667
DOI/URL:
Notes: Article -- Export Date: 12 December 2016 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors